Launched at Advanced Therapies Week 2025, the Advanced Therapies Think Tank (AT3) is an innovative initiative founded by industry leaders Lee Buckler, Sven Kili, Audrey Greenberg and Michelle Boxall, and powered by IB Communications. AT3 is designed to be a dynamic platform that invites open, respectful, and thought-provoking dialogue on the most pressing and controversial issues shaping the future of the advanced therapies industry.

 

In a field marked by rapid innovation and complex challenges, differing perspectives often lead to friction. AT3 embraces these differences, creating a space where industry stakeholders can engage in constructive debate, share bold ideas, and address the tough questions head-on. From ethical considerations and regulatory hurdles to pricing strategies and equitable access, no topic is too challenging or off-limits.

 

Through its inclusive approach, AT3 seeks to foster dynamic debates that tackle contentious issues directly, challenge conventional thinking, and propose actionable solutions. By encouraging diverse perspectives and rigorous discussion, AT3 aims to spark fresh ideas and propel advancements in the advanced therapies ecosystem. Whether you're a researcher, entrepreneur, policymaker, or investor, AT3 provides a unique platform to engage in critical dialogue, question assumptions, and shape the debates driving the future of the industry.

 

Join us as we spark the discussions that will define the next chapter of advanced therapies.